Inhibition of alpha(5)beta(1)integrin with the clinically validated small peptide, ATN-161 stabilizes cerebral vasculature, reduces inflammation, and decreases blood-brain barrier permeability after experimental ischemic stroke

Danielle Edwards; Katie Salmeron; Douglas Lukins; Amanda Trout; Justin Fraser; Gregory Bix

Inhibition of alpha(5)beta(1)integrin with the clinically validated small peptide, ATN-161 stabilizes cerebral vasculature, reduces inflammation, and decreases blood-brain barrier permeability after experimental ischemic stroke

Danielle Edwards, Katie Salmeron, Douglas Lukins, Amanda Trout, Justin Fraser, Gregory Bix

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	FASEB Journal
Volume	33
State	Published - Apr 2019

Fingerprint

Dive into the research topics of 'Inhibition of alpha(5)beta(1)integrin with the clinically validated small peptide, ATN-161 stabilizes cerebral vasculature, reduces inflammation, and decreases blood-brain barrier permeability after experimental ischemic stroke'. Together they form a unique fingerprint.

Cite this

@article{f0f992ae918648828601852e7f8b26f1,

title = "Inhibition of alpha(5)beta(1)integrin with the clinically validated small peptide, ATN-161 stabilizes cerebral vasculature, reduces inflammation, and decreases blood-brain barrier permeability after experimental ischemic stroke",

author = "Danielle Edwards and Katie Salmeron and Douglas Lukins and Amanda Trout and Justin Fraser and Gregory Bix",

year = "2019",

month = apr,

language = "English",

volume = "33",

}

Inhibition of alpha(5)beta(1)integrin with the clinically validated small peptide, ATN-161 stabilizes cerebral vasculature, reduces inflammation, and decreases blood-brain barrier permeability after experimental ischemic stroke. / Edwards, Danielle; Salmeron, Katie; Lukins, Douglas et al.
In: FASEB Journal, Vol. 33, 04.2019.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Inhibition of alpha(5)beta(1)integrin with the clinically validated small peptide, ATN-161 stabilizes cerebral vasculature, reduces inflammation, and decreases blood-brain barrier permeability after experimental ischemic stroke

AU - Edwards, Danielle

AU - Salmeron, Katie

AU - Lukins, Douglas

AU - Trout, Amanda

AU - Fraser, Justin

AU - Bix, Gregory

PY - 2019/4

Y1 - 2019/4

M3 - Meeting Abstract

SN - 0892-6638

VL - 33

JO - FASEB Journal

JF - FASEB Journal

ER -